Sundani Nurono Soewandhi
Overview
Explore the profile of Sundani Nurono Soewandhi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mulyanti D, Soewandhi S, Riani C
Mol Biol Rep
. 2021 Aug;
48(8):5833-5845.
PMID: 34342815
Background: Nowadays, recombinant therapeutic proteins have been widely produced and consumed. For the safety and effectiveness of the protein production, an auto-inducible expression vector is required to replace inducer interference,...
2.
Ainurofiq A, Mauludin R, Mudhakir D, Soewandhi S
Pharmaceutics
. 2018 Jul;
10(3).
PMID: 29986403
Low physical stability is the limitation of the widespread use of amorphous drugs. The co-amorphous drug system is a new and emerging method for preparing a stable amorphous form. Co-amorphous...
3.
Ainurofiq A, Mauludin R, Mudhakir D, Soewandhi S
Res Pharm Sci
. 2018 Apr;
13(2):93-102.
PMID: 29606963
This study describes the formation of multicomponent crystal (MCC) of desloratadine (DES). The objective of this study was to discover the new pharmaceutical MCC of DES using several coformers. The...
4.
Ainurofiq A, Mauludin R, Mudhakir D, Umeda D, Soewandhi S, Putra O, et al.
Eur J Pharm Sci
. 2017 Sep;
111:65-72.
PMID: 28958892
We report the first multicomponent crystal of desloratadine, an important anti-histamine drug, with a pharmaceutically acceptable coformer of benzoic acid. The single crystal structure analysis revealed that this novel multicomponent...
5.
Hiendrawan S, Veriansyah B, Widjojokusumo E, Soewandhi S, Wikarsa S, Tjandrawinata R
Int J Pharm
. 2015 Dec;
497(1-2):106-13.
PMID: 26657269
We report novel pharmaceutical cocrystal of a popular antipyretic drug paracetamol (PCA) with coformer 5-nitroisophhthalic acid (5NIP) to improve its tabletability. The cocrystal (PCA-5NIP at molar ratio of 1:1) was...